Immatics (IMTX)
(Delayed Data from NSDQ)
$12.92 USD
+0.57 (4.62%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $12.95 +0.03 (0.23%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IMTX 12.92 +0.57(4.62%)
Will IMTX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IMTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMTX
Wall Street Analysts Predict a 54.95% Upside in Immatics (IMTX): Here's What You Should Know
Here's Why 'Trend' Investors Would Love Betting on Immatics (IMTX)
IMTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stock Market News for May 15, 2024
Immatics (IMTX) Reports Q1 Loss, Tops Revenue Estimates
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Other News for IMTX
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
Immatics N.V. AGM Concludes Successfully
Tracking Baker Brothers Portfolio - Q1 2024 Update
Immatics N.V. Schedules 2024 Annual Meeting
12 Health Care Stocks Moving In Friday's Intraday Session